Rezolute, Inc. (RZLT)
4.02
+0.15
(+3.88%)
USD |
NASDAQ |
Nov 10, 16:00
4.015
0.00 (0.00%)
After-Hours: 20:00
Rezolute Shareholders Equity (Quarterly) : 85.95M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 85.95M |
| June 30, 2026 | 100.69M |
| March 31, 2026 | 116.83M |
| December 31, 2025 | 128.00M |
| September 30, 2025 | 147.17M |
| June 30, 2025 | 162.13M |
| March 31, 2025 | 82.57M |
| December 31, 2024 | 99.59M |
| September 30, 2024 | 113.44M |
| June 30, 2024 | 121.00M |
| March 31, 2024 | 70.86M |
| December 31, 2023 | 91.73M |
| September 30, 2023 | 103.56M |
| June 30, 2023 | 116.17M |
| March 31, 2023 | 127.32M |
| December 31, 2022 | 141.26M |
| September 30, 2022 | 153.09M |
| June 30, 2022 | 149.47M |
| March 31, 2022 | 51.91M |
| December 31, 2021 | 62.26M |
| September 30, 2021 | 21.56M |
| June 30, 2021 | 26.10M |
| March 31, 2021 | 29.13M |
| December 31, 2020 | 35.89M |
| September 30, 2020 | 4.382M |
| Date | Value |
|---|---|
| June 30, 2020 | 7.365M |
| March 31, 2020 | 10.33M |
| December 31, 2019 | 14.69M |
| September 30, 2019 | 20.62M |
| June 30, 2019 | 1.752M |
| March 31, 2019 | 4.650M |
| December 31, 2018 | -9.788M |
| September 30, 2018 | -6.443M |
| June 30, 2018 | -3.961M |
| March 31, 2018 | 0.5329M |
| December 31, 2017 | 3.802M |
| September 30, 2017 | 7.806M |
| June 30, 2017 | 8.528M |
| March 31, 2017 | 8.460M |
| December 31, 2016 | 7.933M |
| September 30, 2016 | 8.202M |
| June 30, 2016 | 8.773M |
| March 31, 2016 | 5.940M |
| December 31, 2015 | 5.581M |
| September 30, 2015 | 6.758M |
| June 30, 2015 | 9.054M |
| March 31, 2015 | 9.704M |
| December 31, 2014 | 7.817M |
| September 30, 2014 | 5.019M |
| June 30, 2014 | 6.407M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Opus Genetics, Inc. | 38.43M |
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.58M |
| Savara, Inc. | 107.85M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 96.01M |
| Total Liabilities (Quarterly) | 10.06M |
| Debt to Equity Ratio | 0.0088 |
| Current Ratio | 9.916 |
| Net Debt Paydown Yield | 0.04% |